• Centrexion Therapeutics Corporation, a pharmaceutical company developing medicines to treat pain, to manage intellectual property matters including development and implementation of strategies to procure patent protection for multiple small molecule therapeutic agents in human clinical trials
    • Lycera Corporation, a pharmaceutical company developing medicines to treat autoimmune disease and cancer, to manage intellectual property matters including development and implementation of strategies to procure patent protection for multiple small molecule therapeutic agents in human clinical trials
    • Rafael Pharmaceuticals, Inc., a pharmaceutical company developing medicines to treat cancer, to manage intellectual property matters including development and implementation of strategies to procure patent protection for small molecule therapeutic agents being developed for treatment of cancer
    • Implements patent portfolio strategies to establish domestic and international patent protection and performs intellectual property due diligence investigations on behalf of investors, financial institutions, and companies in advance of investments in privately held companies and public offerings of securities for public companies
    • Counsels clients on intellectual property risk assessment, post-grant patent proceedings and disputes concerning ownership, inventorship, validity and infringement of intellectual property rights
    • Develops strategies for maximizing worldwide patent and regulatory exclusivities for companies developing pharmaceuticals
    • Counsels clients on intellectual property contract matters

    Includes matters handled at Dechert or prior to joining the firm.

    • Ball State University, B.S., 1998, summa cum laude
    • University of Illinois at Urbana-Champaign, Ph.D., Chemistry, 2003
    • Boston College Law School, J.D., 2007
    • Massachusetts
    • United States Patent and Trademark Office
    • American Chemical Society
    • American Intellectual Property Law Association
    • Intellectual Property Owners Association
    • Managing Intellectual Property Life Sciences Forum 2020 — Virtual (September 24, 2020)
      Speaker, "Due Diligence Case Study" panel. 
    • 3rd Annual Life-Sciences Patent Network Spring Conference — Boston, MA (April 25, 2019)
      Moderator, "IP Portfolio Management: In-house Counsel Day-to-Day Challenges in Prosecuting and Enforcing Patents."
    • US Life Sciences Industry in the 2018 Landscape: Significant Trends and Developments Explored Webcast — The Knowledge Group (September 5, 2018)